First Bundibugyo Ebola Vaccines Enter Active-Outbreak Efficacy Trial: WHO Clears Moderna, Oxford
· techtimes.com · popularity 18/100 · 0 similar stories today · Public Health & Epidemiology (Health & Life Sciences)
Read the original at techtimes.com →
Summary
WHO backs Moderna and Oxford Ebola vaccine candidates for testing in DRC's Tumaini trial, the first efficacy study targeting the Bundibugyo strain.
Found in: Tech Times. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 11.